<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Patent.org</title>
    <link>https://patent.org</link>
    <description>Patent strategy, applications, portfolio management, and disputes from the Law Office of Michael P. Eddy in San Diego.</description>
    <language>en-us</language>
    <item>
      <title>Boston Scientific Sues Atraverse on a Continuation Patent 22 Days After It Issued</title>
      <link>https://patent.org/lawsuits/boston-scientific-v-atraverse-continuation-patent/</link>
      <guid>https://patent.org/lawsuits/boston-scientific-v-atraverse-continuation-patent/</guid>
      <pubDate>Thu, 08 Oct 2026 12:00:00 GMT</pubDate>
      <description>An October 7 complaint in the District of Delaware asserts at least claims 1 and 22 of U.S. Patent No. 12,733,955 against Atraverse's HOTWIRE guidewire. The application behind it was filed in October 2025, two months after Boston Scientific first sued Atraverse on an earlier patent in the same family.</description>
    </item>
    <item>
      <title>Federal Circuit Affirms in In re Gamble After Pro Se Applicant Forfeited His Indefiniteness Arguments</title>
      <link>https://patent.org/inventors/in-re-gamble-forfeited-indefiniteness-arguments/</link>
      <guid>https://patent.org/inventors/in-re-gamble-forfeited-indefiniteness-arguments/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>In a nonprecedential October 7 opinion, the court affirmed because a pro se applicant forfeited his substantive arguments against indefiniteness rejections under 35 U.S.C. 112(b), both on appeal and before the Board.</description>
    </item>
    <item>
      <title>Federal Circuit Orders USC's Patent Suit Against Google Moved to Northern California</title>
      <link>https://patent.org/lawsuits/in-re-google-usc-transfer-northern-california/</link>
      <guid>https://patent.org/lawsuits/in-re-google-usc-transfer-northern-california/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>In a nonprecedential October 6 order, the Federal Circuit granted Google's petition for a writ of mandamus, vacated the Western District of Texas order denying transfer, and directed the district court to grant Google's motion to the extent that the case is transferred to the Northern District of California under 28 U.S.C. 1404(a).</description>
    </item>
    <item>
      <title>Federal Circuit Gives &quot;Joined&quot; Its Ordinary, Broad Meaning in a Lighted Cover Plate Appeal</title>
      <link>https://patent.org/lawsuits/oreilly-winship-v-snaprays-joined/</link>
      <guid>https://patent.org/lawsuits/oreilly-winship-v-snaprays-joined/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>In a nonprecedential October 5 decision, the court reversed summary judgment of non-infringement on six claims of U.S. Patent No. 9,871,324 and directed partial summary judgment of infringement on claims 1, 2, and 8. It affirmed non-infringement on 17 other claims across both patents.</description>
    </item>
    <item>
      <title>Wearne Digital Sues Pfizer in New York Over Its Cold Chain Distribution</title>
      <link>https://patent.org/lawsuits/wearne-digital-v-pfizer-cold-chain/</link>
      <guid>https://patent.org/lawsuits/wearne-digital-v-pfizer-cold-chain/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>A complaint file-stamped October 2 in the Southern District of New York pleads direct infringement of at least claim 9 of U.S. Patent No. 11,456,067 and asks for an injunction or an ongoing royalty, adding that any requested injunction should be tailored to proven infringement and account for continuity of access to vaccines and other therapeutics.</description>
    </item>
    <item>
      <title>Federal Circuit Affirms That Herbicide-Degrading Enzyme Claims Were Not Enabled</title>
      <link>https://patent.org/lawsuits/pioneer-inari-enablement/</link>
      <guid>https://patent.org/lawsuits/pioneer-inari-enablement/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>A nonprecedential opinion of October 2, 2026, affirms that claims 1 through 33 of U.S. Patent No. 11,371,055 are unpatentable for lack of enablement.</description>
    </item>
    <item>
      <title>How to Spot a Fake Patent Lawyer Before You Pay One</title>
      <link>https://patent.org/practice-watch/how-to-spot-a-fake-patent-lawyer/</link>
      <guid>https://patent.org/practice-watch/how-to-spot-a-fake-patent-lawyer/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>Only registered patent attorneys and agents, and people the USPTO has granted limited recognition, can represent you before the USPTO in a patent application. The register is public, and these five checks use only official sources.</description>
    </item>
    <item>
      <title>Your Provisional Application Just Became More Important</title>
      <link>https://patent.org/inventors/provisional-applications-after-dental-monitoring/</link>
      <guid>https://patent.org/inventors/provisional-applications-after-dental-monitoring/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>A precedential Federal Circuit decision in August 2026 held that a published application gets its provisional's earlier date, for prior-art purposes, only if the provisional supports at least one of the published claims. Thin, hurried provisionals were always risky. Now the risk runs in both directions.</description>
    </item>
    <item>
      <title>What It Means When the PTAB Calls a Decision &quot;Informative&quot;</title>
      <link>https://patent.org/uspto/what-an-informative-ptab-decision-means/</link>
      <guid>https://patent.org/uspto/what-an-informative-ptab-decision-means/</guid>
      <pubDate>Wed, 07 Oct 2026 12:00:00 GMT</pubDate>
      <description>In August 2026 the USPTO designated a Markush-claim appeal decision as informative after a stakeholder nominated it. Informative decisions are not binding, but under the Board's procedures they set out norms that should be followed in most cases, absent justification.</description>
    </item>
  </channel>
</rss>
